top of page

2022 Rome Action Plan on Paediatric HIV & TB

UNAIDS

HIV DIAGNOSTICS

All partners commit to: 

 

163. Address inequities by tackling the stigma and discrimination in communities, schools, and healthcare settings that prevent children living with HIV from accessing testing and treatment. 

164. Increase literacy about CD4 testing and viral load and promote a client-centred approach to support expansion of access to viral load for pregnant and breastfeeding women and children on treatment, including at the point-of-care. 

165. Review and assess emerging co-infections for immunocompromised infants and children, including those with advanced HIV disease, such as severe bacterial infections, fungal infections, and others for country consideration and implementation.

166. Engage affected communities for input and guidance on investment and programmatic priorities, provide support to in-country civil society organizations to engage in advocacy and demand creation for new tools, and ensure data is publicly available to support communities and civil society to monitor progress regarding uptake and implementation of essential diagnostic tools.

Updates

 - 

HIV MEDICINES FOR CHILDREN

UNAIDS commits to:

308. Continuing to support countries to produce estimates of children newly infected with HIV, children living with HIV, and AIDS related deaths among children, along with key indicators around treatment coverage and prevention of vertical transmission, towards the UNAIDS Global report in July. In addition, in collaboration with UNAIDS’ Reference Group on Estimates Modelling and Projections, UNAIDS will continue to pursue methods for collecting robust data on children and HIV.

Updates

 - 

TB TREATMENT for CHILDREN, PREGNANT, POST-PARTUM AND BREASTFEEDING WOMEN

UNAIDS commits to: 

450. Support countries to collect and report data on TB-HIV co-infection, TB treatment initiation and outcomes in children living with HIV. 

Updates

 - 

bottom of page